| Transaction in Own Shares | 31-Dec-2025 | ShareCast |
| Transaction in Own Shares | 30-Dec-2025 | ShareCast |
| Transaction in Own Shares | 29-Dec-2025 | ShareCast |
| Transaction in Own Shares | 23-Dec-2025 | ShareCast |
| Block listing Interim Review | 22-Dec-2025 | ShareCast |
| Total Voting Rights | 02-Jan-2026 | 11:57 | RNS |
| Transaction in Own Shares | 02-Jan-2026 | 07:00 | RNS |
| Transaction in Own Shares | 02-Jan-2026 | 07:00 | RNS |
| Transaction in Own Shares | 31-Dec-2025 | 07:00 | RNS |
| Transaction in Own Shares | 31-Dec-2025 | 07:00 | RNS |
| Ian Norris in new battle to stay in Britain | 27-Feb-2009 | Telegraph |
| Melrose stands out as volumes surge | 20-Feb-2009 | Telegraph |
| Norris loses US extradition battle but says he w... | 26-Jul-2008 | The Independent |
| Fighting fit | 08-Jul-2008 | Sun |
| Morgan Crucible's pension sale | 24-Feb-2008 | Sunday Telegraph |
| Investment Column: Morgan Crucible | 28-Jul-2011 | The Independent |
| Investment Column: Morgan Crucible | 17-Feb-2011 | The Independent |
| Morgan Crucible's reassurance makes it a buy | 03-Aug-2009 | Sunday Telegraph |
| Tempus:Morgan Crucible | 30-Jul-2009 | Times |
| FTSE 100 latest: Energy stocks lift Footsie | 10-Jun-2009 | Daily Mail |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 222.00p |
| Change Today | 4.00p |
| % Change | 1.83 % |
| 52 Week High | 274.00 |
| 52 Week Low | 177.40 |
| Volume | 290,898 |
| Shares Issued | 276.85m |
| Market Cap | £614.60m |
| Beta | 1.16 |
| Value | ![]() |
|---|
| Price Trend | ![]() |
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 11 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 23-Oct-25 | 10-Apr-25 |
| Paid | 17-Nov-25 | 13-May-25 |
| Amount | 5.40p | 6.80p |
| Time | Volume / Share Price |
| 16:36 | 45,000 @ 220.65p |
| 16:35 | 71 @ 222.00p |
| 16:35 | 51 @ 222.00p |
| 16:35 | 69,165 @ 222.00p |
| 16:35 | 215 @ 222.00p |
| CFO | Richard Armitage |
| CEO | Damien Caby |
You are here: research